Advertisements


Alnylam confirms FDA approves Onpattro to treat polyneuropathy caused by hATTR

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 10th, 2018

Alnylam"s Onpattro approved by FDA to treat polyneuropathy caused by hATTR

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 10th, 2018

Alnylam (ALNY) Gets FDA Nod for First-Ever RNAi Therapeutic

Alnylam (ALNY) receives FDA approval for Onpattro to treat polyneuropathy of hereditary transthy.....»»

Category: dealsSource: nytAug 13th, 2018

FDA approves Alnylam"s Onpattro as hATTR treatment

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 10th, 2018

FDA Approves $450,000-a-Year Treatment for Rare Disease

Patients who have hereditary transthyretin-mediated amyloidosis, or hATTR, will take the drug for the rest of their lives. Alnylam Phar.....»»

Category: europeSource: fortuneAug 11th, 2018

Alnylam Reports Improved Onpattro Sales Going Into A Busy Year

Alnylam Reports Improved Onpattro Sales Going Into A Busy Year.....»»

Category: topSource: seekingalphaJan 8th, 2019

Alnylam (ALNY) Reports Preliminary Onpattro Revenues for Q4

Alnylam (ALNY) reports preliminary revenues for Onpattro for the fourth quarter of 2018, and also provides other update.....»»

Category: personnelSource: nytJan 8th, 2019

Alnylam reports better-than-expected Onpattro revenues, says Piper Jaffray

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 7th, 2019

Alnylam announces unaudited Q4 ONPATTRO revenues of $11M-$12M

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 7th, 2019

Lilly to buy Loxo Oncology for about $8 billion in cancer bet

Eli Lilly and Co said on Monday it would buy Loxo Oncology Inc for about $8 billion in cash, buying into a portfolio of targeted medicines to treat cancers caused by rare gene mutations......»»

Category: topSource: moneycentralJan 7th, 2019

Lilly to buy Loxo Oncology in $8 billion cancer push

Eli Lilly and Co said on Monday it would buy Loxo Oncology Inc for about $8 billion in cash, buying into a portfolio of targeted medicines to treat cancers caused by rare gene mutations......»»

Category: topSource: reutersJan 7th, 2019

A Sluggish Start With Onpattro Is Not What Alnylam Shareholders Needed

A Sluggish Start With Onpattro Is Not What Alnylam Shareholders Needed.....»»

Category: topSource: seekingalphaNov 20th, 2018

Alnylam"s Onpattro highly efficacious, safer than competitor, says Piper Jaffray

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 7th, 2018

Alnylam launches ONPATTRO in Germany

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 2nd, 2018

Alnylam announces submission of NDA in Japan for ONPATTRO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 28th, 2018

Alnylam data publication points to positive Onpattro risk profile, says Cowen

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 14th, 2018

Alnylam"s Shares Up as Onpattro Gets FDA and EU Approvals

Zacks.....»»

Category: topSource: redinewsSep 5th, 2018

The Wall Street Journal: FDA approves pair of Merck drugs to treat HIV

Merck & Co. Inc. said Thursday the U.S. Food and Drug Administration has approved two new HIV-1 medicines, Delstrigo and Pifeltro......»»

Category: topSource: marketwatchAug 30th, 2018

Alnylam receives approval of ONPATTRO in Europe

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 30th, 2018

JMP says Pfizer data "impressive," but leave room for Alnylam"s Onpattro

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 28th, 2018

Ionis CRL positive for Alnylam"s Onpattro, says B. Riley FBR

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 28th, 2018